Chemistry: molecular biology and microbiology – Vector – per se
Patent
1994-05-13
1996-04-16
Parr, Margaret
Chemistry: molecular biology and microbiology
Vector, per se
536 232, 536 235, 536 2431, 4351723, 935 9, 935 14, 935 23, C12N 1563, C07H 2102, C07H 2104
Patent
active
055081991
ABSTRACT:
A cloned cDNA encoding debrisoquine 4-hydroxylase gene and a probe for identifying humans having a genetic defect in the metabolism of a certain class of drugs of which debrisoquine is a model, have been prepared. Testing of new drugs and of humans by a simple assay has also been described.
REFERENCES:
patent: 4683194 (1987-07-01), Saiki et al.
Fischer, "The Genetic Polymorphism of Debrisoqune/Sparteine Metabolism-Clinical Aspects", Pharmac. Ther. vol. 46, 1990, pp. 377-394.
Gonzalez, et al., "cDNA-expressed Human Cytochrome P450s: A New Age of Molecular Toxicology and Human Risk Assessment", Mutation Research, 1990, pp. 1-15.
Gonzalez, et al., "Evolution of the P450 Gene Superfamily: Animal-Plant `warfare`, Molecular Drive and Human Genetic Differences in Drug Oxidation", Trends in Genetics, vol. 6, No. 6, 1990, pp. 182-186.
Kimura, et al., "The Human Debrisoquine 4-Hydrozylase (CYP2D) Locus: Sequence and Identification of the Polymorphic CYP2D6 Gene, a Related Gene, and a Pseudogene", Am. J. Hum. Genet., 1989, 45:889-904.
Matsunaga, et al., "Sequence Requirements for Cytochrome P-450IID1 Catalytic Activity", Jour. Bio. Chem., vol. 265, No. 28, Oct. 5, 1990, pp. 17197-17201.
Matsunaga, et al., "The CyP2D Gene Subfamily: Analysis of the Molecular Basis of the Debrisoquine 4-Hydrozylase Deficiency in DA Rats", Biochemistry, 1989, pp. 7349-7355.
Henry Gee, "Bad Medicine", Nature-The Times News Service, London Times, Feb. 5, 1988.
Harold Schmeck, Jr., "Gene Defect Pinpointed in Bad Reactions to Drugs", New York Times, Feb. 4, 1988.
Science Notebook, "Genetic Defect May Cause Lack of Response to Drugs", Washington Post, Feb. 5, 1988.
Gonzalez et al., DNA, "Debrisoquine 4-Hydroxylose . . . ", vol. 6, No. 2, 1987, pp. 149-161.
Skoda et al., PNAS, "Two mutant alleles of the human . . . ", vol. 85, pp. 5240-5243, Jul. 1988.
Gonzalez et al., Nature, "Characterization of the common . . . ", vol. 331, 4 Feb. 1988.
Gonzalez et al., Genomics, "Human Debnsoquine . . . " vol. 2, pp. 174-179 (1988).
Evans et al., J. Med. Genet. 17:101-105 (1980).
Gut et al., FEBS Lett. 173:287-290 (Aug., 1984).
Larrey et al., Biochemistry 23:2787-2795 (1984).
Eichelbaum, Fed. Proc. 43:2298-2302 (May 15, 1984).
Nebert et al., Trends Pharmacol. Sci. 6:160-164 (Apr., 1985).
Gonzalez et al., J. Biol. Chem. 260:7435-7441 (Jun. 25, 1985).
Distlerath et al., J. Biol. Chem. 260:9057-9067 (Jul. 25, 1985).
Gonzalez et al., J. Biol. Chem. 261:10667-10672 (Aug. 15, 1985).
Gut et al., J. Biol. Chem. 261:11734-11743 (Sep. 5, 1986).
Meyer et al., Xenobiotica 16:449-464 (1986).
Eichelbaum et al., Br. J. Clin. Pharmacol. 23:455-458 (1987).
Kronbach et al., Anal. Biochem. 162:24-32 (1987).
Nebert et al., Ann. Rev. Biochem. 56:945-993 (1987).
Gelboin Harry V.
Gonzalez Frank J.
Hardwick James P.
Meyer Urs A.
Myers Carla
Parr Margaret
The United States of America as represented by the Department of
LandOfFree
P450db1 clones for identifying humans with genetic defect in dru does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with P450db1 clones for identifying humans with genetic defect in dru, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and P450db1 clones for identifying humans with genetic defect in dru will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-324642